Hubei Guangji Pharmaceutical Co Ltd (000952) — Cash Flow Reinvestment Rate
Hubei Guangji Pharmaceutical Co Ltd (000952) has a Cash Flow Reinvestment Rate of 0.39x as of September 2025, reinvesting CN¥8.67 Million (capex CN¥8.67 Million ) from operating cash flow of CN¥22.38 Million. See 000952 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hubei Guangji Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Hubei Guangji Pharmaceutical Co Ltd across 20 annual periods. For the full cash flow conversion analysis, see Hubei Guangji Pharmaceutical Co Ltd (000952) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Hubei Guangji Pharmaceutical Co Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Hubei Guangji Pharmaceutical Co Ltd. See 000952 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.59x | CN¥35.64 Million | CN¥60.43 Million | CN¥35.64 Million | ▼ -99.9% |
| 2024 | 469.53x | CN¥307.71 Million | CN¥655.36K | CN¥154.93 Million | ▲ +7360.6% |
| 2022 | 6.29x | CN¥283.71 Million | CN¥45.08 Million | CN¥203.71 Million | ▲ +309.7% |
| 2021 | 1.54x | CN¥116.61 Million | CN¥75.91 Million | CN¥96.61 Million | ▲ +16.1% |
| 2020 | 1.32x | CN¥157.89 Million | CN¥119.38 Million | CN¥97.89 Million | ▲ +6.1% |
| 2019 | 1.25x | CN¥179.76 Million | CN¥144.20 Million | CN¥119.76 Million | ▲ +111.3% |
| 2018 | 0.59x | CN¥136.53 Million | CN¥231.44 Million | CN¥76.53 Million | ▼ -25.1% |
| 2017 | 0.79x | CN¥140.91 Million | CN¥178.83 Million | CN¥80.91 Million | ▼ -40.7% |
| 2016 | 1.33x | CN¥222.03 Million | CN¥167.07 Million | CN¥112.94 Million | ▲ +152.7% |
| 2013 | 0.53x | CN¥50.04 Million | CN¥95.16 Million | CN¥50.04 Million | ▼ -51.6% |
| 2012 | 1.09x | CN¥117.46 Million | CN¥108.02 Million | CN¥117.46 Million | ▼ -55.7% |
| 2011 | 2.45x | CN¥200.96 Million | CN¥81.88 Million | CN¥200.96 Million | ▲ +63.9% |
| 2010 | 1.50x | CN¥115.57 Million | CN¥77.18 Million | CN¥115.57 Million | ▲ +50.4% |
| 2008 | 1.00x | CN¥219.76 Million | CN¥220.70 Million | CN¥219.76 Million | ▲ +575.4% |
| 2007 | 0.15x | CN¥48.94 Million | CN¥331.98 Million | CN¥48.94 Million | ▼ -0.9% |
| 2006 | 0.15x | CN¥18.73 Million | CN¥125.95 Million | CN¥18.73 Million | ▼ -68.8% |
| 2005 | 0.48x | CN¥25.84 Million | CN¥54.14 Million | CN¥25.84 Million | ▼ -28.0% |
| 2002 | 0.66x | CN¥50.52 Million | CN¥76.20 Million | CN¥50.52 Million | ▲ +28.3% |
| 2000 | 0.52x | CN¥25.11 Million | CN¥48.57 Million | CN¥25.11 Million | ▼ -73.9% |
| 1999 | 1.98x | CN¥135.58 Million | CN¥68.57 Million | CN¥135.58 Million | — |